Bernard Fox

Author PubWeight™ 8.61^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.	J Natl Cancer Inst	2004	2.41
2	"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics.	J Immunol	2007	2.11
3	Developments in clinical cell therapy.	Cytotherapy	2010	0.91
4	Endothelial cells co-stimulate peripheral blood mononuclear cell responses to monoclonal antibody TGN1412 in culture.	Cytokine	2011	0.85
5	Antibody C region influences TGN1412-like functional activity in vitro.	J Immunol	2012	0.81
6	The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation.	Clin Chem Lab Med	2014	0.80
7	Anti-D and anti-i activities are inseparable in V4-34-encoded monoclonal anti-D: the same framework 1 residues are required for both reactivities.	Transfusion	2008	0.79
8	International collaborative study to assess candidate reference preparations to control the level of anti-D in IVIG for use in Europe and the United States.	Biologicals	2006	0.75
9	A stable lyophilized reagent for use in a potential reference assay for quantitation of anti-D in immunoglobulin products.	Biologicals	2002	0.75